Edition:
India

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

68.86EUR
23 Aug 2016
Change (% chg)

€-0.70 (-1.01%)
Prev Close
€69.56
Open
€69.56
Day's High
€69.66
Day's Low
€68.62
Volume
2,988,266
Avg. Vol
2,457,546
52-wk High
€93.82
52-wk Low
€62.50

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production... (more)

Overall

Beta: 0.79
Market Cap(Mil.): €89,663.58
Shares Outstanding(Mil.): 1,289.01
Dividend: 2.93
Yield (%): 4.21

Financials

  SASY.PA Industry Sector
P/E (TTM): 21.90 36.30 36.51
EPS (TTM): 3.18 -- --
ROI: 4.96 14.65 14.10
ROE: 7.50 15.54 15.11

Pfizer's Medivation buy seen prescribing more biotech M&A

Medivation's $14 billion sale to U.S. drug giant Pfizer Inc for a hefty premium, the largest U.S. biotechnology acquisition so far this year, had investors on Monday speculating about more dealmaking in the sector.

23 Aug 2016

Pfizer's Medivation buy seen prescribing more biotech M&A

Medivation's $14 billion sale to U.S. drug giant Pfizer Inc for a hefty premium, the largest U.S. biotechnology acquisition so far this year, had investors on Monday speculating about more dealmaking in the sector.

23 Aug 2016

Pfizer's Medivation buy seen prescribing more biotech M&A

Aug 22 Medivation's $14 billion sale to U.S. drug giant Pfizer Inc for a hefty premium, the largest U.S. biotechnology acquisition so far this year, had investors on Monday speculating about more dealmaking in the sector.

23 Aug 2016

Sanofi says talked with Medivation, but will be "disciplined" acquirer

PARIS, Aug 22 French pharmaceutical group Sanofi reacted to Pfizer's roughly $14 billion cash deal for Medivation Inc by saying it had appreciated the chance to engage in talks with Medivation in past weeks.

22 Aug 2016

Delta on long road back to normal after massive flight cancellations

Delta Air Lines faces a "time-consuming process" to restore normal operations and get stranded passengers to their destinations after a power outage caused more than 1,600 flight cancellations over two days, a top executive said on Tuesday.

10 Aug 2016

Thousands of women took Sanofi epilepsy drug despite risk to foetuses - media

PARIS More than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of foetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine.

10 Aug 2016

Thousands of women took Sanofi epilepsy drug despite risk to fetuses: media

PARIS More than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine.

10 Aug 2016

Thousands of women took Sanofi epilepsy drug despite risk to fetuses-media

PARIS, Aug 9 More than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine.

10 Aug 2016

Power outage at Delta causes flight cancellations, delays

Delta Air Lines Inc cancelled hundreds of flights and delayed many others on Monday after an outage hit its computer systems, grounding planes and stranding passengers of one of the world's largest carriers at airports around the globe. | Video

09 Aug 2016

REFILE-UPDATE 3-Regeneron sticks by 2016 growth forecast for Eylea, shares fall

Aug 4 Regeneron Pharmaceuticals Inc stood by its full-year growth forecast for flagship eye drug Eylea as the company posted its slowest growth in revenue in eight quarters.

04 Aug 2016

Earnings vs. Estimates